{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:40:26Z","timestamp":1778830826247,"version":"3.51.4"},"reference-count":80,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":4125,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1016\/s1535-6108(02)00043-0","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T07:26:06Z","timestamp":1034321166000},"page":"237-246","source":"Crossref","is-referenced-by-count":647,"title":["Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein"],"prefix":"10.1016","volume":"1","author":[{"given":"Keiichi","family":"Kondo","sequence":"first","affiliation":[]},{"given":"Jeff","family":"Klco","sequence":"additional","affiliation":[]},{"given":"Eijiro","family":"Nakamura","sequence":"additional","affiliation":[]},{"given":"Mirna","family":"Lechpammer","sequence":"additional","affiliation":[]},{"suffix":"Jr.","given":"William G","family":"Kaelin","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1535-6108(02)00043-0_BIB1","first-page":"3335","article-title":"Growth regulation of human renal carcinoma cells","volume":"52","author":"Atlas","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB2","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1073\/pnas.94.16.8761","article-title":"Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors","volume":"94","author":"Benjamin","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00005072-199605000-00004","article-title":"Expression of growth factors and growth factor receptors in capillary hemangioblastoma","volume":"55","author":"Bohling","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB4","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/jnci\/91.10.854","article-title":"Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma","volume":"91","author":"Brauch","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB5","first-page":"1255","article-title":"Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas","volume":"143","author":"Brown","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB6","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.1066373","article-title":"A conserved family of prolyl-4-hydroxylases that modify HIF","volume":"294","author":"Bruick","year":"2001","journal-title":"Science"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archopht.117.5.625","article-title":"VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma","volume":"117","author":"Chan","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB8","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/hmg\/10.10.1029","article-title":"Contrasting effects on HIF-1\u03b1 regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease","volume":"10","author":"Clifford","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB9","doi-asserted-by":"crossref","first-page":"25733","DOI":"10.1074\/jbc.M002740200","article-title":"Hypoxia inducible factor-\u03b1 binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein","volume":"275","author":"Cockman","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0968-0004(98)01344-9","article-title":"Oncogenic alterations of metabolism","volume":"24","author":"Dang","year":"1999","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB11","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/MCB.21.3.865-874.2001","article-title":"VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling","volume":"21","author":"Davidowitz","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB12","first-page":"1387","article-title":"Role of transforming growth factor-\u03b1 in VHL\u2212\/\u2212 clear cell renal carcinoma cell proliferation","volume":"13","author":"de Paulsen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB13","first-page":"4819","article-title":"Effects of PTK787\/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model","volume":"60","author":"Drevs","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB14","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1126\/science.7660122","article-title":"Inhibition of transcriptional elongation by the VHL tumor suppressor protein","volume":"269","author":"Duan","year":"1995","journal-title":"Science"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB15","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1101\/gad.914801","article-title":"Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1\u03b1","volume":"15","author":"Elson","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","article-title":"C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation","volume":"107","author":"Epstein","year":"2001","journal-title":"Cell"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9440(10)65541-1","article-title":"Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF\/HIF-2\u03b1","volume":"153","author":"Flamme","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB18","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/hmg\/3.12.2169","article-title":"Somatic mutations of the von Hippel-Lindau disease tumor suppressor gene in non-familial clear cell renal carcinoma","volume":"3","author":"Foster","year":"1994","journal-title":"Hum. Mol. Gen."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/(SICI)1098-1004(1999)13:6<464::AID-HUMU6>3.0.CO;2-A","article-title":"Mutations of the VHL gene in sporadic renal cell carcinoma","volume":"13","author":"Gallou","year":"1999","journal-title":"Hum. Mutat."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0594-85","article-title":"Mutations of the VHL tumour suppressor gene in renal carcinoma","volume":"7","author":"Gnarra","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB21","doi-asserted-by":"crossref","first-page":"10589","DOI":"10.1073\/pnas.93.20.10589","article-title":"Post-transcriptional regulation of vascular endothelial growth factor mRNA by the VHL tumor suppressor gene product","volume":"93","author":"Gnarra","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB22","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1073\/pnas.98.4.1583","article-title":"Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor","volume":"98","author":"Haase","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/hmg\/10.10.1019","article-title":"von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF","volume":"10","author":"Hoffman","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB24","first-page":"538","article-title":"Effects of transforming growth factor-beta, transforming growth factor-\u03b1, and other growth factors on renal proximal tubule cells","volume":"64","author":"Humes","year":"1991","journal-title":"Lab. Invest."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB25","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm0895-822","article-title":"Tumor suppression by the human von Hippel-Lindau gene product","volume":"1","author":"Iliopoulos","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB26","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.1073\/pnas.93.20.10595","article-title":"Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein","volume":"93","author":"Iliopoulos","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB27","doi-asserted-by":"crossref","first-page":"11661","DOI":"10.1073\/pnas.95.20.11661","article-title":"pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation","volume":"95","author":"Iliopoulos","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIF\u03b1 targeted for VHL-mediated destruction by proline hydroxylation","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB29","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-\u03b1 to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1126\/science.284.5414.657","article-title":"Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase","volume":"284","author":"Kamura","year":"1999","journal-title":"Science"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB31","doi-asserted-by":"crossref","first-page":"10430","DOI":"10.1073\/pnas.190332597","article-title":"Activation of HIF1a Ubiquitination by a reconstituted von Hippel-Lindau tumor suppressor complex","volume":"97","author":"Kamura","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB32","first-page":"4845","article-title":"Somatic mutations of the von Hippel-Lindau tumor supressor gene in sporadic central nervous systems hemangioblastomas","volume":"54","author":"Kanno","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB33","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.7660130","article-title":"Binding of the von Hippel-Lindau tumor suppressor protein to elongin B and C","volume":"269","author":"Kibel","year":"1995","journal-title":"Science"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB34","first-page":"226","article-title":"Transforming growth factor \u03b1 is a target for the von Hippel-Lindau tumor suppressor","volume":"58","author":"Knebelmann","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB35","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1172\/JCI114759","article-title":"Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells","volume":"86","author":"Kourembanas","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB36","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1038\/sj.onc.1203938","article-title":"Up-regulation of hypoxia-inducible factors HIF-1\u03b1 and HIF-2\u03b1 under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function","volume":"19","author":"Krieg","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB37","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/82146","article-title":"Suppression of tumor growth through disruption of hypoxia-inducible transcription","volume":"6","author":"Kung","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB38","first-page":"544","article-title":"The expression of epidermal growth factor receptor and transforming growth factor \u03b1 in renal cell carcinoma","volume":"7","author":"Lager","year":"1994","journal-title":"Mod. Pathol."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0022-5347(17)42347-0","article-title":"Epidermal growth factor in the normal and neoplastic kidney and bladder","volume":"139","author":"Lau","year":"1988","journal-title":"J. Urol."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB40","first-page":"504","article-title":"Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas","volume":"58","author":"Lee","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2990.2000.00225.x","article-title":"Membranous expression of glucose transporter-1 protein (GLUT-1) in embryonal neoplasms of the central nervous system","volume":"26","author":"Loda","year":"2000","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB42","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1128\/MCB.18.2.732","article-title":"Regulation of hypoxia-inducible mRNAs by the von Hippel-LIndau protein requires binding to complexes containing elongins B\/C and Cul2","volume":"18","author":"Lonergan","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB43","first-page":"386","article-title":"Renal cysts in transgenic mice expressing transforming growth factor-\u03b1","volume":"124","author":"Lowden","year":"1994","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB44","first-page":"2089","article-title":"Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients","volume":"149","author":"Lubensky","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB45","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00005792-199711000-00001","article-title":"von Hippel-Lindau Disease","volume":"76","author":"Maher","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB46","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1093\/emboj\/20.18.5197","article-title":"Independent function of two destruction domains in hypoxia-inducible factor-\u03b1 chains activated by prolyl hydroylation","volume":"20","author":"Masson","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB47","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.94.15.8104","article-title":"Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth","volume":"94","author":"Maxwell","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB48","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The von Hippel-Lindau gene product is necessary for oxgyen-dependent proteolysis of hypoxia-inducible factor \u03b1 subunits","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB49","series-title":"Mendelian Inheritance in Man","author":"McKusick","year":"1992"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB50","first-page":"3407","article-title":"Expression of transforming growth factor \u03b1 and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue","volume":"49","author":"Mydlo","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB51","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0022-5347(01)65028-6","article-title":"Vascular endothelial growth factor expression is increased in renal cell carcinoma","volume":"157","author":"Nicol","year":"1997","journal-title":"J. Urol."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB52","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/bjc.1995.251","article-title":"Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen","volume":"71","author":"Ogawa","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB53","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1172\/JCI8161","article-title":"Synthetic peptides define critical contacts between elongin C, elongin B, and the von hippel-lindau protein","volume":"104","author":"Ohh","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB54","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/35017054","article-title":"Ubiquitination of HIF requires direct binding to the von Hippel-Lindau protein beta domain","volume":"2","author":"Ohh","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB55","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1073\/pnas.94.6.2156","article-title":"The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins","volume":"94","author":"Pause","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB56","doi-asserted-by":"crossref","first-page":"9533","DOI":"10.1073\/pnas.96.17.9533","article-title":"Studying interactions of four proteins in the yeast two-hybrid system","volume":"96","author":"Pause","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB57","first-page":"3934","article-title":"Modulation of pro-epidermal growth factor, pro-transforming growth factor \u03b1 and epidermal growth factor receptor gene expression in human renal carcinomas","volume":"50","author":"Petrides","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB58","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0959-8049(00)00030-7","article-title":"Differential response to transforming growth factor (TGF)-\u03b1 and fibroblast growth factor (FGF) in human renal cell carcinomas of the clear cell and papillary types","volume":"36","author":"Ramp","year":"2000","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB59","first-page":"245","article-title":"Coexpression of transforming growth factor-\u03b1 and epidermal growth factor receptor in capillary hemangioblastomas of the central nervous system","volume":"147","author":"Reifenberger","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB60","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2796.1998.00337.x","article-title":"Haemangioblastoma of the central nervous system in von Hippel-Lindau disease","volume":"243","author":"Richard","year":"1998","journal-title":"J. Int. Med."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB61","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/emboj\/17.11.3005","article-title":"HIF-1\u03b1 is required for solid tumor formation and embryonic vascularization","volume":"17","author":"Ryan","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB62","first-page":"4010","article-title":"Hypoxia-inducible factor-1\u03b1 is a positive factor in solid tumor growth","volume":"60","author":"Ryan","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB63","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1128\/MCB.21.10.3436-3444.2001","article-title":"Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells","volume":"21","author":"Seagroves","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB64","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.cellbio.15.1.551","article-title":"Regulation of Mammalian O2 Homeostasis by Hypoxia-Inducible Factor 1","volume":"15","author":"Semenza","year":"1999","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB65","first-page":"2852","article-title":"Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas","volume":"54","author":"Shuin","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000059976","article-title":"Germline and somatic mutations in von Hippel-Lindau disease gene and its significance in the development of kidney cancer","volume":"128","author":"Shuin","year":"1999","journal-title":"Contrib. Nephrol."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB67","first-page":"2299","article-title":"Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein","volume":"56","author":"Siemeister","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB68","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.284.5413.455","article-title":"Structure of the VHL-ElonginC-elonginB complex","volume":"284","author":"Stebbins","year":"1999","journal-title":"Science"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB69","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/00005072-199711000-00009","article-title":"Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene","volume":"56","author":"Stratmann","year":"1997","journal-title":"J. Neuropath. Exper. Neuro."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB70","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1523-1755.2000.00829.x","article-title":"Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor","volume":"57","author":"Sweeney","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB71","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1093\/emboj\/19.16.4298","article-title":"Mechanism of regulation of the hypoxia-inducible factor-1\u03b1 by the von Hippel-Lindau tumor suppressor protein","volume":"19","author":"Tanimoto","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB72","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0046-8177(97)90075-7","article-title":"von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease","volume":"28","author":"Vortmeyer","year":"1997","journal-title":"Hum. Pathol."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB73","first-page":"2973","article-title":"Altered expression of transforming growth factor-\u03b1 in hereditary rat renal cell carcinoma","volume":"51","author":"Walke","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199101033240101","article-title":"Tumor angiogenesis and metastasis\u2014correlation in invasive breast carcinoma","volume":"324","author":"Weidner","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB75","first-page":"5215","article-title":"Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1\u03b1 in clear cell renal carcinomas","volume":"61","author":"Wiesener","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB76","first-page":"1358","article-title":"Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas","volume":"55","author":"Wizigmann-Voos","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB77","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1073\/pnas.181341498","article-title":"HIF-1\u03b1 binding to VHL is regulated by stimulus-sensitive proline hydroxylation","volume":"98","author":"Yu","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(02)00043-0_BIB78","first-page":"5830","article-title":"Overexpression of hypoxia-inducible factor 1\u03b1 in common human cancers and their metastases","volume":"59","author":"Zhong","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB79","first-page":"620","article-title":"A microscopic dissection technique for archival DNA analysis of specific cell populations in lesions <1mm in size","volume":"146","author":"Zhuang","year":"1995","journal-title":"Amer. J. Path."},{"key":"10.1016\/S1535-6108(02)00043-0_BIB80","first-page":"838","article-title":"Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens","volume":"9","author":"Zhuang","year":"1996","journal-title":"Mod. Pathol."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610802000430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610802000430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T05:52:01Z","timestamp":1554961921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610802000430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S1535610802000430"],"URL":"https:\/\/doi.org\/10.1016\/s1535-6108(02)00043-0","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1008553.122759","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1008553.108066","asserted-by":"object"}]},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}